Despite the challenges of 2020, Dexcom was able to close the year out with financial growth for both the fourth quarter and the full year, according to its earnings report released Thursday.
In the earnings call, Dexcom’s chairman, president and CEO Kevin Sayer voiced his gratitude to the company for surpassing its goals even under the extreme circumstances last year.
“In any given year, these...
Teladoc Health has launched new pilots of its virtual primary care program and hopes to explore its take on a hospital-at-home offering with large health system partners before the end of the year, CEO Jason Gorevic said this week during a J.P. Morgan virtual presentation.
Shortly after the talk, Teladoc also announced a new pilot with continuous glucose monitor (CGM) company Dexcom for eligible...
Shortly before news broke that Teladoc was set to acquire Livongo, the chronic disease management company announced its quarterly earnings results. On Aug. 5 it announced that its second quarter total revenue came in at $91.9 million, which was up 125% YoY. The company reported a GAAP gross margin of 76.6% and non-GAAP gross margin of 77.3%.
The company attributed the gains to its growing...
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.
Despite having some uncertainty in the impacts of the COVID-19 pandemic, Dexcom was able to produce significant year-over-year growth in Q2 2020.
Sayer attributes much of the growth to a steady increase in knowledge...
Anthem has released its COVID-19-tracking and predictive digital platform, C19 Explorer, in partnership with CloudMedx. The tool has five data categories: public health, hospital, economy, social and preventative.
Users can view information on a national, state, county and city level with data on cases, deaths, unemployment, food insecurity and testing. C19 Explorer also includes future hot spot...
For years, Dexcom has been one of the leading competitors in the continuous glucose monitoring space. While the company is focused on looking ahead, that’s not to say there haven’t been some bumps in the road along the way.
In 2018, its Dexcom G6, an integrated continuous glucose monitoring system, got the green light from the FDA, making it the first interoperable CGM to get the designation....
When it comes to the diabetes space, Dexcom is one of the heavy hitters. Its work in the continuous glucose monitoring space has put it on the map. In 2018, its Dexcom G6, an integrated continuous glucose monitoring system, got the greenlight from the FDA, making it the first interoperable CGM to get the designation. This means that it could be part of an integrated system compatible with other...
Consumer virtual health and wellness brand Ro highlighted a new partnership with healthcare API company Ribbon Health that will help users and their virtual providers seek out in-person primary and specialty care services in their area. Accessible within the telehealth platform, the new capability is available across the U.S., and includes information on the types of insurance accepted at each...
This quarter Dexcom raked in $405 million in revenue, compared to $280.5 million in 2019’s Q1. This represents a 44% increase year over year (YoY), and beats the company's revenue goal by $46.7 million. Dexcom attributes its success to its growing user rate.
The gross profits from Q1 were $258.7 million. However, operating expenses have increased, coming in at $215.4 million in 2020 Q1, versus $...
Together in perfect harmony. Dexcom and Welldoc have kicked off a new collaboration that will provide Dexcom G6 continuous glucose monitor users with data-analysis insights from Welldoc's digital diabetes management product, BlueStar. These insights include information on how lifestyle factors such as activity, nutrition, sleep and medication adherence are affecting a user's glucose levels.
“Now...
